Hetero
Yogesh Jaiswal is an experienced professional in business development, currently serving as Deputy General Manager at Hetero since July 2024. Prior to this role, Yogesh held the position of Senior Manager in Portfolio and Business Development at Umedica Laboratories Private Limited from August 2021 to May 2024. Yogesh's career includes notable roles in international operations at Torrent Pharmaceuticals Ltd from June 2018 to July 2021, business development at SUN PHARMA from November 2016 to June 2018, and deputy manager at Mylan Laboratories Limited from July 2012 to October 2016. Earlier experience encompasses a management internship at Torrent Pharmaceuticals Ltd in 2011 and a technical trainee position at Zydus Cadila in 2010. Yogesh completed educational qualifications at SVKM's Narsee Monjee Institute of Management Studies (NMIMS) from 2007 to 2012.
This person is not in any teams
This person is not in any offices
Hetero
4 followers
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc. Hetero has a strong global presence in over 145+ countries and focusses on making affordable medicines accessible to patients worldwide.